LTI-05

N/A

Report date: 2025/01/23 15:52:38

NME

Base Information

Drug NameLTI-05

Drug Alias NameLTI-05

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEpithelial sodium channel inhibitors

TargetsEpithelial sodium channel

Therapy Area/IndicationsCystic Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCystic Fibrosis

Inactive IndicationsN/A

ATC CodeN/A